Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
Purpose
In this study we will find out whether the use of a new type of boost approach called irreversible electroporation (IRE) is as effective as the standard boost approach of radiation therapy for people with intermediate-risk prostate cancer receiving standard stereotactic body radiotherapy (SBRT).
Condition
- Prostate Cancer
Eligibility
- Eligible Ages
- Between 18 Years and 99 Years
- Eligible Sex
- Male
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Biopsy proven grade group 2 or 3 (GS 3+4 or GS 4+3) cancer with all pattern 4 found only in the MRI target - Gland size ≤ 80 cc - Prostate MRI < rT3b disease - IPSS < 20 - No contraindication to IRE, RT, anesthesia, or transperineal procedure
Exclusion Criteria
- Any Grade Group ≥4 disease, or any cribriform and/or intraductal carcinoma - Evidence of nodal or /metastatic disease on MRI and/or PSMA PET/CT - Unfit for general anesthesia, or contraindication/hypersensitivity to required neuromuscular blocking agents - Active urinary tract infection (UTI) at the time of IRE or biopsy; must be treated and resolved prior to proceeding - Actively bleeding, known bleeding disorder, or inability to interrupt anticoagulants/antiplatelet therapy as clinically indicated for biopsy/IRE safety - Any history of cardiac arrhythmia or epilepsy, or recent myocardial infarction, consistent with NanoKnife contraindication statements - Presence of an implanted pacemaker/defibrillator or other active implanted electronic device, or other device-related contraindications per current NanoKnife labeling/user manual - Inability to undergo pelvic MRI - Prior treatment of prostate cancer including androgen deprivation therapy, focal therapy, radiation therapy, or prostatectomy - Current or intended use of androgen deprivation therapy
Study Design
- Phase
- Phase 3
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Treatment
- Masking
- None (Open Label)
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Experimental IRE Boost Arm |
Participants will receive Irreversible Electroporation |
|
|
Active Comparator RT Boost Arm |
Participants will receive Radiation Therapy and will serve as the control arm |
|
Recruiting Locations
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Basking Ridge, New Jersey 07920
Basking Ridge, New Jersey 07920
Contact:
Himanshu Nagar, MD
212-639-6478
Himanshu Nagar, MD
212-639-6478
Memorial Sloan Kettering at Monmouth (Limited Protocol Activities)
Middletown, New Jersey 07748
Middletown, New Jersey 07748
Contact:
Himanshu Nagar, MD
212-639-6478
Himanshu Nagar, MD
212-639-6478
Memorial Sloan Kettering at Bergen (Limited Protocol Activities)
Montvale, New Jersey 07645
Montvale, New Jersey 07645
Contact:
Himanshu Nagar, MD
212-639-6478
Himanshu Nagar, MD
212-639-6478
Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities)
Commack, New York 11725
Commack, New York 11725
Contact:
Himanshu Nagar, MD
212-639-6478
Himanshu Nagar, MD
212-639-6478
Memorial Sloan Kettering at Westchester (Limited Protocol Activities)
Harrison, New York 10604
Harrison, New York 10604
Contact:
Himanshu Nagar, MD
212-639-6478
Himanshu Nagar, MD
212-639-6478
Memorial Sloan Kettering Cancer Center (All Protocol Activites)
New York, New York 10065
New York, New York 10065
Contact:
Himanshu Nager, MD
212-639-6478
Himanshu Nager, MD
212-639-6478
Memorial Sloan Kettering at Nassau (Limited Protocol Activities)
Uniondale, New York 11553
Uniondale, New York 11553
Contact:
Himanshu Nagar, MD
212-639-6478
Himanshu Nagar, MD
212-639-6478
More Details
- Status
- Recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center